awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42107886-39655EA5-5A0D-455A-B81C-D2728123D151
Q42107886-39655EA5-5A0D-455A-B81C-D2728123D151
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42107886-39655EA5-5A0D-455A-B81C-D2728123D151
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
P2860
Q42107886-39655EA5-5A0D-455A-B81C-D2728123D151
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42107886-39655EA5-5A0D-455A-B81C-D2728123D151
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eab4bf9f98b4d2658c2d26d33b27b95468e75330
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.